| Literature DB >> 34344887 |
Andrew T Timberlake1, Casey Griffin2, Carrie L Heike3,4, Anne V Hing3,4, Michael L Cunningham3,4, David Chitayat5,6, Mark R Davis7, Soghra J Doust8, Amelia F Drake9, Milagros M Duenas-Roque10, Jack Goldblatt11, Jonas A Gustafson3, Paula Hurtado-Villa12, Alexis Johns13, Natalya Karp14, Nigel G Laing15, Leanne Magee16, Sureni V Mullegama17, Harry Pachajoa18, Gloria L Porras-Hurtado19, Rhonda E Schnur17,20, Jennie Slee11, Steven L Singer21, David A Staffenberg22, Andrew E Timms4, Cheryl A Wise7, Ignacio Zarante23,24, Jean-Pierre Saint-Jeannet2, Daniela V Luquetti25,26.
Abstract
Craniofacial microsomia (CFM) is the second most common congenital facial anomaly, yet its genetic etiology remains unknown. We perform whole-exome or genome sequencing of 146 kindreds with sporadic (n = 138) or familial (n = 8) CFM, identifying a highly significant burden of loss of function variants in SF3B2 (P = 3.8 × 10-10), a component of the U2 small nuclear ribonucleoprotein complex, in probands. We describe twenty individuals from seven kindreds harboring de novo or transmitted haploinsufficient variants in SF3B2. Probands display mandibular hypoplasia, microtia, facial and preauricular tags, epibulbar dermoids, lateral oral clefts in addition to skeletal and cardiac abnormalities. Targeted morpholino knockdown of SF3B2 in Xenopus results in disruption of cranial neural crest precursor formation and subsequent craniofacial cartilage defects, supporting a link between spliceosome mutations and impaired neural crest development in congenital craniofacial disease. The results establish haploinsufficient variants in SF3B2 as the most prevalent genetic cause of CFM, explaining ~3% of sporadic and ~25% of familial cases.Entities:
Year: 2021 PMID: 34344887 DOI: 10.1038/s41467-021-24852-9
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919